Modulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the Heart

Oxidative Medicine and Cellular Longevity
Csaba CsonkaTamás Csont

Abstract

Hypercholesterolemia is a frequent metabolic disorder associated with increased risk for cardiovascular morbidity and mortality. In addition to its well-known proatherogenic effect, hypercholesterolemia may exert direct effects on the myocardium resulting in contractile dysfunction, aggravated ischemia/reperfusion injury, and diminished stress adaptation. Both preclinical and clinical studies suggested that elevated oxidative and/or nitrative stress plays a key role in cardiac complications induced by hypercholesterolemia. Therefore, modulation of hypercholesterolemia-induced myocardial oxidative/nitrative stress is a feasible approach to prevent or treat deleterious cardiac consequences. In this review, we discuss the effects of various pharmaceuticals, nutraceuticals, some novel potential pharmacological approaches, and physical exercise on hypercholesterolemia-induced oxidative/nitrative stress and subsequent cardiac dysfunction as well as impaired ischemic stress adaptation of the heart in hypercholesterolemia.

References

Jan 1, 1991·Basic Research in Cardiology·H H KleinP Schuff-Werner
Feb 1, 1990·Journal of Molecular and Cellular Cardiology·M van BilsenR S Reneman
Dec 1, 1986·Journal of the American College of Cardiology·P L CannerW Friedewald
Jan 8, 1981·The New England Journal of Medicine·R B ShekelleW J Raynor
Feb 1, 1995·Cardiovascular Drugs and Therapy·S D BellowsR A Kloner
Mar 18, 1995·BMJ : British Medical Journal·K Imai, K Nakachi
Aug 15, 1994·Archives of Biochemistry and Biophysics·E M BastiaanseA Van der Laarse
May 1, 1994·The American Journal of Physiology·Z SzilvassyM Koltai
Nov 1, 1996·Circulation·B C GhoP D Verdouw
Jun 1, 1997·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·T T Yang, M W Koo
Apr 4, 1998·Journal of Molecular and Cellular Cardiology·P FerdinandyL Dux
Nov 10, 1998·Circulation·B StaelsJ C Fruchart
Aug 3, 2000·American Journal of Physiology. Heart and Circulatory Physiology·N A TruebloodS Schaefer
Sep 7, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·B A Kingwell
Oct 14, 2000·Annual Review of Cell and Developmental Biology·J J Repa, D J Mangelsdorf
Mar 7, 2001·Antioxidants & Redox Signaling·B KaltschmidtC Kaltschmidt
Aug 2, 2001·Biochemical and Biophysical Research Communications·C CsonkaP Ferdinandy
Jan 5, 2002·Journal of the American College of Nutrition·F L Crane
Jan 5, 2002·Physiological Reviews·Wulf Dröge
Apr 27, 2002·The American Journal of Clinical Nutrition·Tunde PatakiArpad Tosaki
Jan 9, 2003·JAMA : the Journal of the American Medical Association·Margaret M RedfieldRichard J Rodeheffer
Jan 16, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Nina SkottováLadislav Cvak
Jun 12, 2003·Cardiovascular Research·Annamária OnodyPéter Ferdinandy
Jul 2, 2003·Nutrition·Undurti N Das
Jul 16, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Zhi-Qing ZhaoJakob Vinten-Johansen
Sep 5, 2003·Basic Research in Cardiology·Zoltán GiriczPéter Ferdinandy
Nov 14, 2003·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·U J JungM S Choi
Nov 18, 2003·Journal of Applied Physiology·Mark A ThompsonM Harold Laughlin
Dec 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Katharina GausWendy Jessup
Jun 5, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Nina SkottováJitka Ulrichová

❮ Previous
Next ❯

Citations

Jun 25, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Hyun-Ho LeeMin-Ho Oak
May 19, 2018·Human & Experimental Toxicology·O AtliS Ilgin
Jul 28, 2018·Phytotherapy Research : PTR·Chin Xuan TanHasanah Mohd Ghazali
Jan 4, 2020·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Rita HameisterGurpal Singh
May 17, 2018·Oncotarget·Márta SárközyTamás Csont
May 13, 2020·Redox Report : Communications in Free Radical Research·Abdulaziz M S AlSaadSalim S Al-Rejaie
May 30, 2020·International Journal of Molecular Sciences·Márton R SzabóTamás Csont
Jun 4, 2020·Animals : an Open Access Journal From MDPI·Tatiana Dumitra PanaiteCristina Soica
May 26, 2020·Environmental Science and Pollution Research International·Mohammad H AbukhalilAyman M Mahmoud
Feb 25, 2020·BioMed Research International·Li ZhangJunfang Teng
Aug 6, 2020·International Journal of Environmental Research and Public Health·Supattra Prom-InJaya Kumar
Jul 29, 2017·Lipids in Health and Disease·Csaba CsonkaTamás Csont
Mar 27, 2018·Oxidative Medicine and Cellular Longevity·Rodrigo L CastilloCatalina Carrasco-Pozo
Apr 20, 2018·Naunyn-Schmiedeberg's Archives of Pharmacology·Jin-Ting YangLing-Bo Qian
Oct 24, 2019·International Urology and Nephrology·Maryam JabarpourAmirhesam Alirezaei
Oct 2, 2020·Journal of Food Science·Yusuf SaiduSuleiman Alhaji Muhammad
Nov 2, 2019·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Naveen KaushalParminder Kaur
Sep 13, 2020·Biochimica Et Biophysica Acta. Molecular Cell Research·Yun Yeong LeeYun-Hoon Choung
Dec 16, 2020·International Journal of Molecular Sciences·Márton Richárd SzabóCsaba Csonka
Feb 17, 2021·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Márta SárközyTamás Csont
Mar 8, 2021·Molecular and Cellular Biochemistry·Subramani YuvarajGovindan Sadasivam Selvam
Sep 15, 2018·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Tamara AtkinsonJonathan R Lindner
Apr 9, 2021·Nutrition & Metabolism·Porrnthanate SeenakNitirut Nernpermpisooth
May 21, 2021·Current Hypertension Reports·Piotr DubinskiAgnieszka Cudnoch-Jedrzejewska
Aug 8, 2021·International Journal of Pharmaceutics·Wen LiQiang Fu
Nov 5, 2019·Journal of Agricultural and Food Chemistry·Yunxia YangJianfa Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2022 Meta ULC. All rights reserved